BioMarin Pharma (BMRN) Reports In-Line Q2 EPS
Tweet
Share
E-mail
Get Alerts BMRN Hot Sheet
Price: $67.36 -1.71%
Financial Fact:
Intangible asset amortization and contingent consideration: 9.65M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Financial Fact:
Intangible asset amortization and contingent consideration: 9.65M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
BioMarin Pharma (NASDAQ: BMRN) reported Q2 GAAP EPS of ($0.21), in-line with the analyst estimate of ($0.21). Revenue for the quarter came in at $317.4 million versus the consensus estimate of $308.96 million.
For earnings history and earnings-related data on BioMarin Pharma (BMRN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- Newton Golf Company (NWTG) Reports Q2 Loss of $0.49
- Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
